Latest Divestments News

Health and Plant Protein Group Limited (HPP) reported a reduced net loss of $528,000 for FY2025, following the receipt of final proceeds from its US divestment. The Board signals plans to return capital and pursue new corporate opportunities.

Rural Funds Group reported FY25 results aligned with forecasts, showcasing steady distributions and a diversified agricultural portfolio. The group maintains solid gearing and advances key development projects while forecasting stable AFFO and distributions for FY26.

Rural Funds Group reported a solid FY25 with rising property and farming income driven by macadamia developments, while maintaining stable distributions and preparing for significant capital expenditure in FY26.

Accent Group reported steady FY25 sales of $1.62 billion with a slight dip in profits, while advancing its Sports Direct rollout and extending key brand agreements.

BCI Minerals has transitioned to full-scale operations at its Mardie Salt Project, marking a pivotal moment with strong construction progress, secured financing, and binding offtake agreements. The company remains on track for first salt shipment by late 2026.

EOS has reported a 126% increase in its contract backlog to $307 million in 1H 2025, driven by strong demand for its defence and space technologies despite a revenue decline. The company secured a landmark €71.4 million high energy laser weapon export contract and continues to strengthen its balance sheet.

Electro Optic Systems reveals a challenging half-year with a steep revenue drop and loss from continuing operations, offset by a substantial gain from divesting EM Solutions and a major new laser weapons contract.

AMA Group Limited reported a robust FY25 with revenue climbing 8.6% to over $1 billion and a 38.4% jump in normalised EBITDA, while significantly reducing net debt following a major equity raise and debt refinancing.

BCI Minerals reported a $47 million net loss for FY25, driven by heavy spending on the Mardie Salt and Potash Project, while gains from the Iron Valley asset sale partially offset the hit.

Healius Limited reported a 5.7% rise in FY25 revenue driven by pathology growth, while underlying EBIT fell 27% impacted by cyclone disruptions and restructuring. The company advances its pathology strategy and cost savings post-Lumus divestment.

Healius reported a 5.7% rise in FY25 revenue with underlying EBIT meeting consensus, buoyed by strong pathology growth and a significant profit from the Lumus Imaging sale. Despite challenges at Agilex Biolabs and a major goodwill impairment, the company targets improved margins by 2027.

Eureka Group Holdings reports robust FY25 results with double-digit revenue and profit growth, boosted by strong rental demand and strategic acquisitions. The company signals continued expansion and operational efficiency improvements ahead.